Monocarboxylate transporter 8 deficiency: Altered thyroid morphology and persistent high triiodothyronine/thyroxine ratio after thyroidectomy

European Journal of Endocrinology

Volumn 165, Issue 4, 2011, Pages 555-561

  Wirth, Eva K ^a   Sheu, Sien Yi ^b   Chiu Ugalde, Jazmin ^a   Sapin, Remy ^c   Klein, Marc O ^d   Mossbrugger, Ilona ^e   Quintanilla Martinez, Leticia ^e,f   Hrabě De Angelis, Martin ^e,g   Krude, Heiko ^a   Riebel, Thomas ^a   Rothe, Karin ^a   Köhrle, Josef ^a   Schmid, Kurt W ^b   Schweizer, Ulrich ^a   Grüters, Annette ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

^f UNIVERSITY OF TÜBINGEN   (Germany)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; MONOCARBOXYLATE TRANSPORTER 8; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASE REPORT; CHILD; CONTROLLED STUDY; DEIODINATION; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; ECHOGRAPHY; FIBROSIS; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; METABOLIC DISORDER; MONOCARBOXYLATE TRANSPORTER 8 DEFICIENCY; MOUSE; NONHUMAN; NORMAL VALUE; PATHOLOGICAL ANATOMY; POSTOPERATIVE CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; THYROID FUNCTION TEST; THYROID HYPERPLASIA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; THYROXINE BLOOD LEVEL;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, PAPILLARY, FOLLICULAR; CHILD; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; IODIDE PEROXIDASE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCARBOXYLIC ACID TRANSPORTERS; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; RNA; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY; THYROXINE; TREATMENT OUTCOME; TRIIODOTHYRONINE;

EID: 80053482206     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0369     Document Type: Article

References (26)

1. Friesema EC, Grueters A, Biebermann H, Krude H, Von Moers A, Reeser M, Barrett TG, Mancilla EE, Svensson J, Kester MH, Kuiper GG, Balkassmi S, Uitterlinden AG, Koehrle J, Rodien P, Halestrap AP & Visser TJ. Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 2004 364 1435-1437. (doi:10.1016/S0140-6736(04) 17226-7)
2. Dumitrescu AM, Liao XH, Best TB, Brockmann K & Refetoff S. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. American Journal of Human Genetics 2004 74 168-175. (doi:10.1086/380999)
3. Schwartz CE, May MM, Carpenter NJ, Rogers RC, Martin J, Bialer MG, Ward J, Sanabria J, Marsa S, Lewis JA, Echeverri R, Lubs HA, Voeller K, Simensen RJ & Stevenson RE. Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. American Journal of Human Genetics 2005 77 41-53. (doi:10.1086/431313)
4. Friesema EC, Visser WE & Visser TJ. Genetics and phenomics of thyroid hormone transport by MCT8. Molecular and Cellular Endocrinology 2010 222 107-113. (doi:10.1016/j.mce.2010.01.016)
5. Hennemann G, Docter R, Friesema EC, De Jong M, Krenning EP & Visser TJ. Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocrine Reviews 2001 22 451-476. (doi:10.1210/er.22.4.451)
6. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP & Visser TJ. Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. Journal of Biological Chemistry 2003 278 40128-40135. (doi:10.1074/jbc.M300909200)
7. Kinne A, Kleinau G, Hoefig CS, Grü ters A, Köhrle J, Krause G & Schweizer U. Essential molecular determinants for thyroid hormone transport and first structural implications for monocarboxylate transporter 8. Journal of Biological Chemistry 2010 285 28054-28063. (doi:10.1074/jbc.M110. 129577)
8. Dumitrescu AM, Liao XH, Weiss RE, Millen K & Refetoff S. Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. Endocrinology 2006 147 4036-4043. (doi:10.1210/en.2006-0390)
9. Trajkovic M, Visser TJ, Mittag J, Horn S, Lukas J, Darras VM, Raivich G, Bauer K & Heuer H. Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. Journal of Clinical Investigation 2007 117 627-635. (doi:10.1172/JCI28253)
10. Ceballos A, Belinchon MM, Sanchez-Mendoza E, Grijota- Martinez C, Dumitrescu AM, Refetoff S, Morte B & Bernal J. Importance of monocarboxylate transporter 8 for the blood-brain barrier-dependent availability of 3,5,3′-triiodo-L-thyronine. Endocrinology 2009 150 2491-2496. (doi:10.1210/en.2008-1616)
11. 3transporter mutated in Allan-Herndon-Dudley syndrome. Journal of Neuroscience 2009 29 9439-9449. (doi:10.1523/JNEUROSCI.6055-08.2009)
12. Di Cosmo C, Liao XH, Dumitrescu AM, Philp NJ, Weiss RE & Refetoff S. Mice deficient in MCT8 reveal a mechanism regulating thyroid hormone secretion. Journal of Clinical Investigation 2010 120 3377-3388. (doi:10.1172/JCI42113)
13. Trajkovic-Arsic M, Muller J, Darras VM, Groba C, Lee S, Weih D, Bauer K, Visser TJ & Heuer H. Impact of monocarboxylate transporter-8 deficiency on the hypothalamus-pituitary-thyroid axis in mice. Endocrinology 2010 151 5053-5062. (doi:10.1210/en.2010-0593)
14. Biebermann H, Ambrugger P, Tarnow P, Von Moers A, Schweizer U & Grueters A. Extended clinical phenotype, endocrine investigations and functional studies of a loss-of-function mutation A150V in the thyroid hormone specific transporter MCT8. European Journal of Endocrinology 2005 153 359-366. (doi:10.1530/eje.1.01980)
15. Kinne A, Roth S, Biebermann H, Köhrle J, Grü ters A & Schweizer U. Surface translocation and tri-iodothyronine uptake of mutant MCT8 proteins are cell type-dependent. Journal of Molecular Endocrinology 2009 43 263-271. (doi:10.1677/JME-09-0043)
16. Streckfuss F, Hamann I, Schomburg L, Michaelis M, Sapin R, Klein MO, Köhrle J & Schweizer U. Hepatic deiodinase activity is dispensable for the maintenance of normal circulating thyroid hormone levels in mice. Biochemical and Biophysical Research Communications 2005 337 739-745. (doi:10.1016/j.bbrc.2005.09.102)
17. Friedrichs B, Tepel C, Reinheckel T, Deussing J, Von Figura K, Herzog V, Peters C, Saftig P & Brix K. Thyroid functions of mouse cathepsins B, K, and L. Journal of Clinical Investigation 2003 111 1733-1745. (doi:10.1172/JCI15990)
18. Schomburg L, Riese C, Michaelis M, Griebert E, Klein MO, Sapin R, Schweizer U & Köhrle J. Synthesis and metabolism of thyroid hormones is preferentially maintained in selenium-deficient transgenic mice. Endocrinology 2006 147 1306-1313. (doi:10.1210/en.2005-1089)
19. Knostman KA, Jhiang SM & Capen CC. Genetic alterations in thyroid cancer: the role of mouse models. Veterinary Pathology 2007 44 1-14. (doi:10.1354/vp.44-1-1)
20. Knauf JA, Ma X, Smith EP, Zhang L, Mitsutake N, Liao XH, Refetoff S, Nikiforov YE & Fagin JA. Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation. Cancer Research 2005 65 4238-4245. (doi:10.1158/0008-5472. CAN-05-0047)
21. Powell DJ Jr, Russell J, Nibu K, Li G, Rhee E, Liao M, Goldstein M, Keane WM, Santoro M, Fusco A & Rothstein JL. The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids. Cancer Research 1998 58 5523-5528. (Pubitemid 28551140)
22. Jin L, Burniat A, Dumont JE, Miot F, Corvilain B & Franc B. Human thyroid tumours, the puzzling lessons from E7 and RET/PTC3 transgenic mice. British Journal of Cancer 2008 99 1874-1883. (doi:10.1038/sj.bjc.6604740)
23. Stocker DJ & Burch HB. Thyroid cancer yield in patients with Graves' disease. Minerva Endocrinologica 2003 28 205-212.
24. Hishinuma A, Fukata S, Kakudo K, Murata Y & Ieiri T. High incidence of thyroid cancer in long-standing goiters with thyroglobulin mutations. Thyroid 2005 15 1079-1084. (doi:10.1089/thy.2005.15.1079)
25. Camargo R, Limbert E, Gillam M, Henriques MM, Fernandes C, Catarino AL, Soares J, Alves VA, Kopp P & Medeiros-Neto G. Aggressive metastatic follicular thyroid carcinoma with anaplastic transformation arising from a long-standing goiter in a patient with Pendred's syndrome. Thyroid 2001 11 981-988. (doi:10.1089/105072501753211073)
26. Senou M, Khalifa C, Thimmesch M, Jouret F, Devuyst O, Col V, Audinot JN, Lipnik P, Moreno JC, van Sande J, Dumont JE, Many MC, Colin IM & Gerard AC. A coherent organization of differentiation proteins is required to maintain an appropriate thyroid function in the Pendred thyroid. Journal of Clinical Endocrinology and Metabolism 2010 95 4021-4030. (doi:10.1210/jc.2010-0228)